Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetershill Regulatory News (PHLL)

  • This share is currently suspended. It was suspended at a price of 310.50
  • There is currently no data for PHLL

Total Voting Rights

2 Oct 2023 07:01

RNS Number : 2554O
Petershill Partners PLC
02 October 2023
 

2nd October 2023

 

 

PETERSHILL PARTNERS PLC

(the "Company")

 

TOTAL VOTING RIGHTS

 

 

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, as at 30th September 2023, the Company had 1,127,757,392 Ordinary Shares in issue, each with equal voting rights. No shares are held in treasury. Therefore, the total number of voting rights in the Company is 1,127,757,392.

 

Shareholders should use 1,127,757,392 as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

-ENDS-

Ocorian Administration (UK) Limited (Company Secretary)

Theresa Beard                                      +44 777 5658 193

                                                           gsam@ocorian.com

Analyst / Investor enquiries:

Gurjit Kambo                                         + 44 (0) 207 051 2564

                                                        Gurjit.Kambo@gs.com

 

Media enquiries:

Brunswick Group Advisory Limited                  PHLL@brunswickgroup.com

Simone Selzer                                                 + 44 (0) 207 404 5959

                                                                       sselzer@brunswickgroup.com

Issued by Petershill Partners Plc

LEI: 213800HTCF8A7XM22A32

Registered in England and Wales No. 13289144

Registered office: 5th Floor, 20 Fenchurch Street, London, England, EC3M 3BY

 

ABOUT PETERSHILL PARTNERS plc.

Petershill Partners plc (the "Company" or "Petershill Partners") and its Subsidiaries (the "Group") is a diversified, global alternatives investment group focused on private equity and other private capital strategies. Through our economic interests in 25 alternative asset management firms ("Partner-firms"), we provide investors with exposure to the growth and profitability of the alternative asset management industry. The Company completed its initial acquisition of the portfolio of Partner-firms on 28 September 2021 and was admitted to listing and trading on the London Stock Exchange on 1 October 2021 (ticker: PHLL). The Company is operated by Goldman Sachs Asset Management ("Goldman Sachs" or the "Operator") and is governed by a diverse and fully independent Board of Directors (the "Board").

 

Through our Partner-firms, we have exposure to $300 billion of total assets under management ("AuM"), comprising a diverse set of more than 200 long-term private equity and other private capital funds where capital is typically locked in over a multi-year horizon. These underlying funds generate recurring management fees and the opportunity for meaningful profit participation over the typical 8+ year lifecycles of such funds. We believe our approach is aligned with the founders and managers of our Partner-firms and, as a result, allows the Company to participate in these income streams in a way that provides high-margin, diversified and stable cash flows for our shareholders.

 

For more information, visit https://www.petershillpartners.com. Information on the website is not incorporated by reference into this press release and is provided merely for convenience.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBIGDCBDDDGXC
Date   Source Headline
13th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20227:00 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 20227:00 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSTransaction in Own Shares
31st May 20222:30 pmRNSResult of AGM
31st May 20227:00 amRNSTransaction in Own Shares
30th May 20227:00 amRNSTransaction in Own Shares
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20227:00 amRNSTransaction in Own Shares
25th May 20227:00 amRNSQ1 Trading Update
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20227:00 amRNSTransaction in Own Shares
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSTransaction in Own Shares
18th May 20227:00 amRNSTransaction in Own Shares
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSShare Buyback Programme of up to USD$50 Million
3rd May 202211:17 amRNSDirector/PDMR Shareholding
29th Apr 20227:00 amRNSNotice of AGM and Proposed Final Dividend
27th Apr 20227:00 amRNS2021 Annual Report and Accounts
20th Apr 20227:00 amRNSFull-Year Financial Results
18th Jan 20227:00 amRNSAcquisition Update
16th Dec 202112:30 pmRNSDirector/PDMR Shareholding
26th Nov 20219:37 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSQ3 Trading Update
3rd Nov 20212:51 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotice of Q3 2021 Trading Statement Release
1st Nov 20217:00 amRNSTotal Voting Rights
28th Oct 20217:00 amRNSExercise of Over-allotment Option
28th Oct 20217:00 amRNSEnd of Stabilisation Notice
26th Oct 20214:36 pmRNSStabilisation Notice
19th Oct 20214:36 pmRNSStabilisation Notice
12th Oct 20214:36 pmRNSStabilisation Notice
11th Oct 20214:21 pmRNSHolding(s) in Company
8th Oct 202111:01 amRNSHolding(s) in Company
7th Oct 202112:45 pmRNSHolding(s) in Company
7th Oct 202112:30 pmRNSHolding(s) in Company
5th Oct 20214:36 pmRNSStabilisation Notice
1st Oct 20218:30 amRNSDirector/PDMR Shareholding
1st Oct 20218:00 amRNSAdmission to Trading on the London Stock Exchange
28th Sep 202112:59 pmRNSAnnouncement of Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.